Fasenra pen 30 MG/mlml
Ended Awarded Last action
- Contract number
- SPE2DR26FJXG0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,494
Award facts
- Contract value 100% obligated
- $2,493.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,493.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of FASENRA Pen 30 mg/ml. This firm fixed-price delivery order, issued on January 29, 2026, with an ultimate completion date of January 30, 2026, was awarded without set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. The delivery will be performed at the contractor's Park Ridge location and represents a routine pharmaceutical supply fulfillment within DMS Pharmaceutical Group's extensive federal distribution operations.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide. The IDC, designated SPE2DR and valued at up to $499,999,999, was awarded to DMS Pharmaceutical Group on November 13, 2025, and extends through December 31, 2036, positioning the company as a regional prime vendor contractor authorized to supply branded and generic pharmaceuticals, biologics, and medical consumables to support recurring military medical needs globally.
Quick answers
Who was awarded contract SPE2DR26FJXG0?
SPE2DR26FJXG0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FJXG0 worth?
The government has obligated $2,494 on SPE2DR26FJXG0.
Is contract SPE2DR26FJXG0 an order under another contract?
Yes. SPE2DR26FJXG0 is a delivery order under SPE2DR25D9307, an indefinite delivery contract.
Was contract SPE2DR26FJXG0 competed?
The extent of competition for SPE2DR26FJXG0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award